FSSAI suspends Dior Pharmaceuticals licence; bars products from Vatave and Neuherbs

FSSAI issued prohibition orders over manufacturing non-compliance, misleading claims and labelling issues. Dior Pharmaceuticals must halt nutraceutical operations, while Vatave Health Care and Global Healthfit Retail India have been directed to stop specified products.

— Source publishedThu, 30 Jul, 2026, 19:19 IST·First seen Thu, 30 Jul, 2026, 19:24 IST·Source The Hindu BusinessLine

What happened

FSSAI suspended Dior Pharmaceuticals’ licence over critical manufacturing non-compliance and ordered it to halt nutraceutical operations. It also barred Vatave

Key facts

  • FSS Act 2006
  • FSS Regulations 2016
  • 30 days

Why this matters

Treat nutraceutical compliance systems, product-claim substantiation and regulatory liabilities as priority diligence items in any deal involving affected or comparable wellness brands.

Also reported by